Dr Becky Inkster University positionHonorary Research Fellow Departmentsbi212@medschl.cam.ac.uk Home pagehttp://www.beckyinkster.com (personal home page) Research ThemesDevelopmental NeuroscienceSystems and Computational NeuroscienceThe Cambridge Neuroscience CommunityDigital Youth Culture...InterestsI am a Neuroscientist passionate about digital interventions in mental health, social media data analysis, genomics, molecular biology, and neuroimaging. I am passionate about working with hard-to-reach, disadvantaged groups and youth culture.I am a Co-Founder of HIP HOP PSYCH, which uses hip-hop as a vehicle for cultivating awareness about mental health, for public engagement, teaching innovation, refining psychotherapies and psychoeducation.I have further interests in GSK3beta, EPO clinical trials for mood disorders and how the human kinome maps to disease and health.My affiliations include:Honorary Research Fellow, Department of Psychiatry, University of Cambridge, UKVisiting Scholar, School of Social Work, Columbia University, NYC, USACo-Founder of Hip Hop PsychAcademic Freelance (Sole Trader)Touchkin AdvisorConference Lead: Digital Interventions in Mental Health I am interested in learning how social networking site data, such as social network structure, can help us understand mental health conditionsClick image to view full-sizeResearch Focus
EquipmentBehavioural analysisImmunohistochemistryMagnetic resonance imaging (MRI)Neuropsychological testingRandomised control trialsTurntablesCollaboratorsNo collaborators listed Associated News Items
Key publicationsInkster B, Kosinski M, Stillwell D (in submission), “Neuroscience in the digital age” Nature NeuroscienceInkster B, Stillwell D, Kosinski M, Jones P (in submission), “A decade into Facebook: where is psychiatry in the digital age?” The Lancet PsychiatryMiskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Køster N, Inkster B, Paulson OB, Kessing LV, Skimminge A, Siebner HR (2015), “Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders” Biol Psychiatry 78(4): 270-7Sule A, Inkster B (2015), “Kendrick Lamar, street poet of mental health” The Lancet Psychiatry 2(6): 496-7Publicationsin submissionInkster B, Simmons A, Cole J, Schoof E, Linding R, Nichols T, Whitcher B, Muglia P, Rao A, Auer DP, Holsboer F, Saemann P, McGuffin P, Fu C, Zai G, Miskowiak KW, Matthews PM, Nicodemus K (in submission), “Replicated epistasis relates to GSK3beta, hippocampal volume and major depressive disorder” Molecular PsychiatryInkster B, Zai G, Lewis G, Miskowiak KW (in submission), “GSK3β: a plausible mechanism of hippocampal change induced by erythropoietin treatment in mood disorders” Molecular Psychiatry2015Inkster B Sule A (2015), “Drug term trends in American hip-hop lyrics ” Journal of Public Mental Health 14(3): 169-173Toseeb U, Inkster B (2015), “Online social networking sites and mental health research” Front Psychiatry 6(36): 1-42014Sule A, Inkster B (2014), “A hip-hop state of mind” The Lancet Psychiatry 1(7):494-52013Inkster B, Strijbis EM, Vounou M, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ (2013), “Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.” Neurobiol Aging 34(1):238-47 DetailsStrijbis EM, Inkster B, Vounou M, Naegelin Y, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ (2013), “Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.” Mult Scler 19(3):281-8 DetailsWeiskopf N, Suckling J, Williams G, Correia MM, Inkster B, Tait R, Ooi C, Bullmore ET, Lutti A (2013), “Quantitative multi-parameter mapping of R1, PD(*), MT, and R2(*) at 3T: a multi-center validation.” Front Neurosci7:95 Details2012Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ (2012), “GABA system dysfunction in autism and related disorders: from synapse to symptoms.” Neurosci Biobehav Rev 36(9):2044-55 DetailsInkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM (2012), “Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.” Neurobiol Aging 33(3):457-65 Details2011Dixson L, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM, Inkster B (2011), “Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls.” Psychoneuroendocrinology 36(6):929-34 DetailsInkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM (2011), “Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms.” J Neuroimaging 21(4):375-82 Details2010Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2010), “Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression.” Neuroimage 53(3):908-17 DetailsMiskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ (2010), “Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.” Psychopharmacology (Berl) 210(3):419-28 Details2009Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2009), “Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.” Arch Gen Psychiatry 66(7):721-8 DetailsMiskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ (2009), “Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.” Psychopharmacology (Berl) 207(1):133-42 Details2008Mannie ZN, Norbury R, Murphy SE, Inkster B, Harmer CJ, Cowen PJ (2008), “Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression.” Br J Psychiatry 192(5):356-61 DetailsMiskowiak K, Inkster B, O'Sullivan U, Selvaraj S, Goodwin GM, Harmer CJ (2008), “Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.” Exp Brain Res184(3):313-21 DetailsMiskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ (2008), “Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.” Neuropsychopharmacology33(3):611-8 Details2007Miskowiak K, Inkster B, Selvaraj S, Goodwin G, Harmer C (2007), “Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration.” Psychopharmacology (Berl) 195(3):451-3 Details2004Inkster B, Muglia P, Jain U, Kennedy JL (2004), “Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder.” Psychiatr Genet 14(2):117-20 Details2002Muglia P, Jain U, Inkster B, Kennedy JL (2002), “A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD.” Neuropsychopharmacology 27(4):655-62 Details |
Cambridge Neuroscience |